Skip to main content

Table 1 Body and uterine weight in mice fed soy isoflavones and administered LPS.

From: Soy isoflavones avert chronic inflammation-induced bone loss and vascular disease

Treatment

Body wt (g)

Uterine wt (g)

0 IF Placebo

19.0 ± 0.3

0.12 ± 0.01

0 IF LPS

19.6 ± 0.4

0.11 ± 0.01

126 IF Placebo

19.6 ± 0.2

0.12 ± 0.01

126 IF LPS

19.4 ± 0.3

0.13 ± 0.01

504 IF Placebo

19.7 ± 0.3

0.11 ± 0.01

504 IF LPS

19.7 ± 0.2

0.13 ± 0.01

P value

  

LPS

0.4703

0.1457

IF

0.3844

0.4305

LPS*IF

0.3933

0.2276

  1. Mice were fed soy isoflavones (IF; 0, 126 or 504 mg aglycone equivalents of IF/kg diet) for 14-days prior to and during a 30-day exposure to LPS (1.33 μg/d). Results are expressed as means ± standard error.
Back to article page

Journal of Inflammation

ISSN: 1476-9255

Contact us